Exhibition

ACCEL ELISA COVID19 TEST KIT

Negotiable Pieces | Min Order Quantity Unit
Required
Quantity
Place of Origin
South Korea
Brand name
ACCEL ELISA COVID19 test kit
Payment Terms
L/C,T/T
Production
method
OEM,ODM,Available
Shipping /
Lead Time
Negotiable / Negotiable
Keyword
corona, serology, testing kit, covid19,
Category
Medical Test Kit

2 Plexense

Supplier Activity

tradeKorea provides seller activity to buyers throu gh seller evaluation and measurement according to each item.

  • Country

    South Korea South Korea

    Verified Certificate

      ISO GMP
    • KITA
    Product name ACCEL ELISA COVID19 TEST KIT Certification CE
    Category Medical Test Kit Ingredients -
    Keyword corona , serology , testing kit , covid19 Unit Size 158.0 * 93.0 * 103.0 mm
    Brand name ACCEL ELISA COVID19 test kit Unit Weigh 250 g
    origin South Korea Stock 0
    Supply type OEM,ODM,Available HS code 382200
    Product Information

     

     

    https://www.youtube.com/watch?v=8wyjd7DqLR0

    ACCEL ELISA® COVID-19 Total Antibody Kit

     

    This test kit is a serology-based SARS-CoV-2 total antibody detection assay which utilizes Plexense’s proven and patented ACCEL ELISA® technology for sensitive, rapid and accurate results.

     

    The ACCEL ELISA® COVID-19 assay uses the SARS-CoV-2 nucleocapsid protein (N-protein) developed by the BioNano Health Guard Research Center (a division of the Ministry of Science and ICT, Korea) in collaboration with Korea Research Institute of Bioscience and Biotechnology (KRIBB) for the sole use of COVID-19 antibody detection on ACCEL ELISA® platform.

     

    The ACCEL ELISA® has greatly simplified the tedious process of conventional ELISA test method through its patented well-design technology. Now, laboratories and test centers worldwide have the option of selecting and deploying ELISA tests across all their facilities without the need for exotic equipment. Each ACCEL ELISA® COVID-19 kit can test up to 94 patient samples simultaneously in just under 30 minutes.  In terms of daily testing capacity, ramping up to 3,000 or even 10,000 tests per day is as simple as adding clinical staff and basic laboratory instruments.  It is that simple and quick, and all possible due to the new ACCEL ELISA® technology. 

     

    In terms of accuracy, ACCEL ELISA® COVID-19 Kit has a 98.5% overall agreement to real time PCR testing method.  At the heart of Plexense’s ACCEL ELISA® technology is the precision-cut “starburst” design. This was designed with the intent to improve antibody capture from any angle within the well and optimize surface chemistry for higher sensitivity and better performance.  Based on recent clinical assessment of 341 patient samples shows that the ACCEL ELISA® COVID-19 Kit performed at a sensitivity of 100% and a specificity of 100% for patients with 5 or more days onset of infection. 

    Why choose ACCEL ELISA® over other platforms? 

     

    ·Quick testing turnaround for the detection of total antibodies (IgA, IgM, IgG) against SARS-Cov-2 antigens 

    ·Highly improved sensitivity over lateral flow (immunochromatography) method 

    ·High-throughput testing available up to 94 patient samples at a single run ·96-well strip plate formatted 

    ·Compatible with standard plate reader (OD read at 650nm) 

    ·Sample type & volume required per well: 10 μL human blood serum 

    ·30 minutes Assay time 

    ·Validation of assay with 341 patient sera samples confirmed high accuracy results –Sensitivity 94.4%, Specificity 100%, Overall Agreement with RT-PCR 98.5%

    B2B Trade
    Price (FOB) Negotiable transportation Air Transportation
    MOQ Negotiable Leadtime Negotiable
    Payment Options L/C,T/T Shipping time Negotiable

    2 Plexense

    • Country

      South Korea South Korea
    • Supplier Activity

    • President

      KIM GI BEOM

    • Address

      17015, Giheung-gu, Yongin-si, Gyeonggi-do, Korea

    • Product Category

      Medical Test Kit

    • Year Established

      2012

    • No. of Total Employees

      1-50

    • Company introduction

      We are Plexense Inc., a South Korean company that specializes in the development and production of a fast and cost-effective ELISA immunoassay platform for clinical, food and life science testing.

      Currently we are focusing on diagnostic kits for the COVID-19.

       

      Our kit is an advanced ELISA platform which is very cost-effective, patented technology that makes the accuracy of our product excellent.

       

      If you have more questions about our diagnostic kit for the Covid-19, Please don’t hesitate to contact us or you also can visit our website: www.plexense.com to register your interest or review our product information. 

       

       

    • Main Markets
      • Brazil Brazil
      • Canada Canada
      • Colombia Colombia
      • Indonesia Indonesia
      • India India
      • Philippines Philippines
      • Pakistan Pakistan
      • South Africa South Africa
    • Main Product
      • ACCEL ELISA COVID19 TEST KIT

        ACCEL ELISA COVID19 TEST KIT


      • ACCEL ELISA COVID_19 Saliva Antigen Kit

        ACCEL ELISA COVID-19 Saliva Antigen Kit

    • Attached File

      ACCEL ELISA® COVID-19 Kit.pdf

    • Verified Certificate CE
    • Other Products from This Supplier

      ACCEL ELISA COVID-19 Saliva Antigen Kit

    • Related Products

      Covid 19 Detection

      I-STEM (Y-STEM) PRP KIT

      Nurugo CPR manikin

      A+CheQ COVID-19 High-Speed RT-qPCR Detection Kit

      Contour Test strips, Accu chek, One Touch, On Call Plus

    • TRADE SHOWs "Gunpo Expo 2022"

      PLASTIC INJECTION MOLD

      Pospion 6000TK

      Posture Corrector Chair Curble KIDS

      SHE'S LAB THE ICELAND AQUA SERUM

      SP-3000

    • Other Products viewed with This Product